Cargando…

(S)-2-(Cyclobutylamino)-N-(3-(3,4-dihydroisoquinolin-2(1H)-yl)-2-hydroxypropyl)isonicotinamide Attenuates RANKL-Induced Osteoclast Differentiation by Inhibiting NF-κB Nuclear Translocation

Osteoporosis is a common skeletal disease; however, effective pharmacological treatments still need to be discovered. This study aimed to identify new drug candidates for the treatment of osteoporosis. Here, we investigated the effect of EPZ compounds, protein arginine methyltransferase 5 (PRMT5) in...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ding, Mina, Cho, Eunjin, Chen, Zhihao, Park, Sang-Wook, Lee, Tae-Hoon
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10002170/ https://www.ncbi.nlm.nih.gov/pubmed/36901758 http://dx.doi.org/10.3390/ijms24054327

Ejemplares similares

4-Cyclobutylamino-3-nitrobenzoic acid
por: Narendra Babu, Shivanagere Nagojappa, et al.
Publicado: (2009)

Crucial Role of Lysine-Specific Histone Demethylase 1 in RANKL-Mediated Osteoclast Differentiation
por: Ding, Mina, et al.
Publicado: (2023)

2-Hydroxy-3,3-dimethyl-7-nitro-3,4-dihydroisoquinolin-1(2H)-one
por: Ben Salah, Hassen, et al.
Publicado: (2008)

2-(4-Bromophenyl)-3,4-dihydroisoquinolin-2-ium thiocyanate hemihydrate
por: Ma, Yanni, et al.
Publicado: (2011)

2-(2-Hydroxyphenyl)-3,4-dihydroisoquinolin-1(2H)-one
por: Yang, Jian, et al.
Publicado: (2011)

In Silico Screening for Novel Leucine Aminopeptidase Inhibitors with 3,4-Dihydroisoquinoline Scaffold
por: Ziemska, Joanna, et al.
Publicado: (2020)

N-Aryl-3,4-dihydroisoquinoline Carbothioamide Analogues as Potential Urease Inhibitors
por: Ali, Fayaz, et al.
Publicado: (2021)

Chiral phosphoric acid-catalyzed enantioselective phosphinylation of 3,4-dihydroisoquinolines with diarylphosphine oxides
por: Guo, Yongbiao, et al.
Publicado: (2023)

Synthesis of 3,4-dihydroisoquinolin-1(2H)-one derivatives and their antioomycete activity against the phytopathogen Pythium recalcitrans
por: Wang, Delong, et al.
Publicado: (2023)

2-(Substituted phenyl)-3,4-dihydroisoquinolin-2-iums as Novel Antifungal Lead Compounds: Biological Evaluation and Structure-Activity Relationships
por: Hou, Zhe, et al.
Publicado: (2013)

Synthesis of 8-Fluoro-3,4-dihydroisoquinoline and Its Transformation to 1,8-Disubstituted Tetrahydroisoquinolines
por: Hargitai, Csilla, et al.
Publicado: (2018)

Palladium-catalyzed regio- and stereoselective synthesis of aryl and 3-indolyl-substituted 4-methylene-3,4-dihydroisoquinolin-1(2H)-ones
por: Nori, Valeria, et al.
Publicado: (2020)

6,7-Dimethoxy-3-methoxycarbonyl-1-(2-methoxyphenyl)-3,4-dihydroisoquinoline 2-oxide
por: Naicker, Tricia, et al.
Publicado: (2011)

Facile Synthesis of Tricyclic 1,2,4-Oxadiazolines-Fused Tetrahydro-Isoquinolines from Oxime Chlorides with 3,4-Dihydroisoquinoline Imines
por: Wang, Kaikai, et al.
Publicado: (2022)

Isonicotinamide–2-naphthoic acid (1/1)
por: Madeley, Lee G., et al.
Publicado: (2011)

Synthesis and Pharmacological Evaluation of New 3,4-Dihydroisoquinolin Derivatives Containing Heterocycle as Potential Anticonvulsant Agents
por: Zhang, Hong-Jian, et al.
Publicado: (2016)

Substrate-Controlled Diversity-Oriented Synthesis of Novel Polycyclic Frameworks via [4 + 2] and [3 + 2] Annulations of Ninhydrin-Derived MBH Adducts with 3,4-Dihydroisoquinolines
por: Wang, Kaikai, et al.
Publicado: (2023)

Methyl 1-cyclohexyl-6,7-dimethoxy-3,4-dihydroisoquinoline-3-carboxylate
por: Naicker, Tricia, et al.
Publicado: (2011)

(3R,4S)-3-Methyl-4-phenyl-2-[(R)-1-phenylethyl]-3,4-dihydroisoquinolin-2-ium tetrafluoridoborate
por: Ben Ali, Karim, et al.
Publicado: (2014)

New 2-aryl-7,8-dimethoxy-3,4-dihydroisoquinolin-2-ium salts as potential antifungal agents: synthesis, bioactivity and structure-activity relationships
por: Zhu, Lifei, et al.
Publicado: (2017)

Facile and diastereoselective arylation of the privileged 1,4-dihydroisoquinolin-3(2H)-one scaffold
por: Dar’in, Dmitry, et al.
Publicado: (2022)

Design, Synthesis and Biological Evaluation of 1,4-Disubstituted-3,4-dihydroisoquinoline Compounds as New Tubulin Polymerization Inhibitors
por: Zhang, Ling, et al.
Publicado: (2015)

IRF2 enhances RANKL-induced osteoclast differentiation via regulating NF-κB/NFATc1 signaling
por: Kim, Inyoung, et al.
Publicado: (2021)

Rh(iii)-catalyzed synthesis of tetracyclic isoquinolinium salts via C–H activation and [4+2] annulation of 1-phenyl-3,4-dihydroisoquinolines and alkynes in ethanol
por: Dang, Xinxin, et al.
Publicado: (2018)

RNA-binding protein Musashi2 induced by RANKL is critical for osteoclast survival
por: Fujiwara, T, et al.
Publicado: (2016)

PSTP-3,5-Me Inhibits Osteoclast Differentiation and Bone Resorption
por: Cho, Eunjin, et al.
Publicado: (2019)

New Derivatives of 3,4-Dihydroisoquinoline-3-carboxylic Acid with Free-Radical Scavenging, d-Amino Acid Oxidase, Acetylcholinesterase and Butyrylcholinesterase Inhibitory Activity
por: Solecka, Jolanta, et al.
Publicado: (2014)

Access to 1-amino-3,4-dihydroisoquinolines via palladium-catalyzed C–H bond aminoimidoylation reaction from functionalized isocyanides
por: Xiong, Zhuang, et al.
Publicado: (2019)

Crystal structure of tetrakis(isonicotinamide-κN)bis(thiocyanato-κN)cobalt(II)–isonicotinamide–ethanol (1/2/1)
por: Neumann, Tristan, et al.
Publicado: (2016)

Introduction of chirality at C1 position of 1-substituted-3,4-dihydroisoquinoline by its enantioselective reduction: synthesis of chiral 1-substituted-1,2,3,4-tetrahydroisoquinoline – a review
por: Asif, Md. Moaz Ahmed, et al.
Publicado: (2023)

Copper(ii)-catalyzed and acid-promoted highly regioselective oxidation of tautomerizable C(sp(3))–H bonds adjacent to 3,4-dihydroisoquinolines using air (O(2)) as a clean oxidant
por: He, Yun-Gang, et al.
Publicado: (2021)

1-Oxo-3,4-dihydroisoquinoline-4-carboxamides as novel druglike inhibitors of poly(ADP-ribose) polymerase (PARP) with favourable ADME characteristics
por: Safrygin, Alexander, et al.
Publicado: (2021)

Berberine Sulfate Attenuates Osteoclast Differentiation through RANKL Induced NF-κB and NFAT Pathways
por: Zhou, Lin, et al.
Publicado: (2015)

Reactivity of 3-Ethoxycarbonyl Isoquinolinium Salts Towards Various Nucleophilic Reagents: Applications to the Synthesis of New 1,2-Dihydroisoquinoline-3-carboxylates
por: Meziane, Mohamed Ameziane Aït Amer, et al.
Publicado: (2002)

Piceatannol attenuates RANKL-induced osteoclast differentiation and bone resorption by suppressing MAPK, NF-κB and AKT signalling pathways and promotes Caspase3-mediated apoptosis of mature osteoclasts
por: Yan, Liuliu, et al.
Publicado: (2019)

4-Carbamoylpyridin-1-ium 2,2,2-trichloroacetate–isonicotinamide (1/1)
por: Perdih, Franc
Publicado: (2012)

Signaling crosstalk between RANKL and interferons in osteoclast differentiation
por: Takayanagi, Hiroshi, et al.
Publicado: (2002)

Inhibitory Effects of N-[2-(4-acetyl-1-piperazinyl) phenyl]-2-(2-chlorophenoxy) acetamide on Osteoclast Differentiation In Vitro via the Downregulation of TRAF6
por: Chen, Zhihao, et al.
Publicado: (2019)

Bajijiasu Abrogates Osteoclast Differentiation via the Suppression of RANKL Signaling Pathways through NF-κB and NFAT
por: Hong, Guoju, et al.
Publicado: (2017)

β-Boswellic Acid Inhibits RANKL-Induced Osteoclast Differentiation and Function by Attenuating NF-κB and Btk-PLCγ2 Signaling Pathways
por: Park, Gyeong Do, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_3b37h8t7hg30ol8t0t3j4hsneq